France ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis

France ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis


$ 3999

France's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $813 Mn in 2022 to $1,345 Mn in 2030 with a CAGR of 6.5% for the year 2022-30. The increased prevalence of ADHD in France and rising investments in mental health services are the major market drivers for the growth of the market. The France ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Novasep, Poxel, and Adlon Therapeutics are the key players in the market.

ID: IN10FRPH028 CATEGORY: Pharmaceuticals GEOGRAPHY: France AUTHOR: Parul Choudhary

Buy Now

France Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Executive Analysis

The France Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market size is at around $813 Mn in 2022 and is projected to reach $1,345 Mn in 2030, exhibiting a CAGR of 6.5% during the forecast period. France's Gross Domestic Product (GDP) included 11.2% of healthcare spending. This is a little bit more than the OECD's average expenditure, which in the same year was 8.8% of GDP. In 2022, France spent about $278.12 Bn on healthcare, with about 76% of that cost coming from public funds like the national health insurance scheme. Individual out-of-pocket expenses made up about 8% of total healthcare spending, while commercial health insurance made up about 14% of the total. All citizens of France have access to healthcare facilities under the country's universal health coverage scheme, regardless of their financial or social standing. The foundation of the French healthcare system is a combination of insurance plans and state and private healthcare providers.

ADHD (attention deficit hyperactivity disorder) affects about 5% of children and is frequently present in adults (up to 80% of the time). With heredity playing a part in ADHD, up to 3.5% of adults may have the disorder, with rates much greater in parents of children who have been diagnosed. According to the most recent study that is available, the prevalence rate for children aged 6 to 12 in France varies from 3.5% to 5.6%. Furthermore, it determines that 3.48% of kids between the ages of 6 and 12 receive psychostimulant therapy.

There are currently no neurological markers, genetic markers, or biological tests to detect or support the diagnosis of hyperactivity, despite decades of intensive study. As a result, only behavioral symptoms—namely, an attention deficiency with or without motor impulsivity and hyperactivity—are evaluated in the description of ADHD. Due to this, there is a considerable worldwide discussion surrounding the prevalence of ADHD. Since 1995, methylphenidate has been authorized for the therapy of ADHD in France. Up until 2002, the number of minors receiving prescriptions was very low, but after that, it increased dramatically, by 11% annually. In 2013, about 0.5% of French children and adolescents got at least one medication. Therefore, according to the advocates of this medication, ADHD is not properly recognized or managed in France.

france attention deficit hyperactivity disorder market analysis

Market Dynamics

Market Growth Drivers

ADHD is becoming more common everywhere, including in France. In children aged 6 to 17 in France, the prevalence of ADHD was calculated to be around 3.5%, according to research that was published in the journal European Child & Adolescent Psychiatry. The demand for ADHD therapeutics in France is anticipated to increase as a result of this increasing prevalence.

Improvements in ADHD therapeutics have been made due to ongoing study and development. This covers the development of novel medications as well as non-pharmacological therapies like cognitive behavioral therapy. The France ADHD therapeutics market is anticipated to expand as a result of these developments.

There will probably be more money invested in mental health services, including ADHD treatment, as healthcare costs rise in France. The market for ADHD therapeutics in France is anticipated to expand as a result.

Market Restraints

In some regions, there is still a shortage of qualified mental health professionals despite the French government's attempts to increase access to mental health services. This may restrict the accessibility and supply of ADHD therapeutics in some areas, slowing the France ADHD therapeutics market's expansion. Despite increased knowledge of ADHD, there is still some stigma attached to the disorder. Due to the underdiagnosis and undertreatment of ADHD, the market for ADHD therapeutics in France may not expand as quickly as it might otherwise.

Competitive Landscape

Key Players

  • ENYO Pharma (FRA)
  • Laboratoire Aguettant (FRA)
  • AddiPsy (FRA)
  • Novasep (FRA)
  • Poxel (FRA)
  • Adlon Therapeutics
  • Amnel Pharmaceuticals
  • Aytu Biopharma
  • American Brivision
  • Cingulate
  • Eli Lilly
  • GSK
  • Johnson & Johnson

Healthcare Policies and Regulatory Landscape

The French National Agency for Medicines and Health Products Safety (Agence Nationale de Sécurité du Médicament et des Produits de Santé or ANSM) is the regulatory authority in charge of overseeing pharmaceuticals in France. The French Ministry of Health oversees ANSM, a public organization tasked with assessing, regulating, and maintaining the safety, efficacy, and quality of pharmaceuticals, medical equipment, and cosmetics. Additionally, the agency releases specialized reports like the Annual Report on the State of Health in France and one for EU citizens who use the French healthcare system. The French medicines agency is also in charge of overseeing patient-involved clinical studies conducted in France, early access programs, and the reimbursement process for novel medications. The ANSM is involved in both the importation of medicines into France and pharmacovigilance activities, which include collecting and analyzing any data on adverse effects on patients' health associated with the use of medications and vaccines the agency has approved.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Segmentation

By Drug Type (Revenue, USD Billion):

  • Stimulants
    • Amphetamine
    • Methylphenidate
    • Dextroamphetamine
    • Dexmethylphenidate
    • Lisdexamfetamine
    • Others
       
  • Non-Stimulants
    • Atomoxetine
    • Bupropion
    • Guanfacine
    • Clonidine

By Age Group (Revenue, USD Billion):

  • Pediatric And Adolescent
  • Adult

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Speciality Clinics
  • Retail Pharmacies
  • e-Commerce

By Psychotherapy (Revenue, USD Billion):

  • Behavior Therapy
  • Cognitive Behavioral Therapy
  • Interpersonal Psychotherapy
  • Family Therapy

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 23 March 2023
Updated by: Dhruv Joshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up